WX [WuXi PharmaTech (Cayman)] CT ORDER: (Original Filing)
[]
YGE [YINGLI GREEN ENERGY] 424B5: (Original Filing)
[The information in this preliminary prospectus supplement is notmplete and may be changed. This preliminary prospectus supplement and accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer orle is not permitted. Subject tompletion,ted June15, 2009]
YGE [YINGLI GREEN ENERGY] 6-K: (Original Filing)
[Yingli Green Energympany Limited [ ] American Depositary Shares Form of Underwritingreement June [ ], 2009 Deutsche Bank Securitieshedule I and the other several Underwriter[s] named in c/o Deutsche Bank Securities 60 Wall Street Ladies and Gentlemen: be; and any reference herein to the terms amend, amendment or supplement with respect to the Registration Statement,]
YGE [YINGLI GREEN ENERGY] 6-K: Yingli Green Energympany Limited [ ] American Depositary
[Yingli Green Energympany Limited [ ] American Depositary Shares Form of Underwritingreement June [ ], 2009 Deutsche Bank Securitieshedule I and the other several Underwriter[s] named in c/o Deutsche Bank Securities 60 Wall Street Ladies and Gentlemen: be; and any reference herein to the terms amend, amendment or supplement with respect to the Registration Statement,]
YGE [YINGLI GREEN ENERGY] F-6: (Original Filing)
[TABLE OFNTENTS POWER OF ATTORNEY PART 1 CROSS REFERENCE SHEET Item1. DESCRIPTION OF SECURITIES TO BE REGISTERED Location in Form of American Depositary Item Number andption Receipt Filed Herewith Prospectus (1) Name anddress of Depositary Introductory paragraph (2) Title of American Depositary Receipts and identity of deposited securities Terms of Deposit:] [June15, 2009 JPMorgan Chase Bank, Ladies and Gentlemen: American Depositary Shares evidenced by American Depositary Receipts for deposited ordinary shares of Yingli Green Energympany LimitedSsRsmpany Depositreement Referring to the Registration Statement on Form F-6 relating to theove-entitled American Depositary Shares ( We are of the opinion that theSsvered by the Registration Statement, when issued in] [Certification under Rule466 The depositary, JPMorgan Chase Bank, represents and certifies the following: (1)That it previously had filed a registration statement on Form F-6 (Yingli Green Energympany Limited, 333-142852) that themmission declared effective, with terms of deposit identical to the terms of deposit of this registration statement.]
YGE [YINGLI GREEN ENERGY] F-6: TABLE OFNTENTS POWER OF ATTORNEY PART 1 CROSS
[TABLE OFNTENTS POWER OF ATTORNEY PART 1 CROSS REFERENCE SHEET Item1. DESCRIPTION OF SECURITIES TO BE REGISTERED Location in Form of American Depositary Item Number andption Receipt Filed Herewith Prospectus (1) Name anddress of Depositary Introductory paragraph (2) Title of American Depositary Receipts and identity of deposited securities Terms of Deposit:] [June15, 2009 JPMorgan Chase Bank, Ladies and Gentlemen: American Depositary Shares evidenced by American Depositary Receipts for deposited ordinary shares of Yingli Green Energympany LimitedSsRsmpany Depositreement Referring to the Registration Statement on Form F-6 relating to theove-entitled American Depositary Shares ( We are of the opinion that theSsvered by the Registration Statement, when issued in] [Certification under Rule466 The depositary, JPMorgan Chase Bank, represents and certifies the following: (1)That it previously had filed a registration statement on Form F-6 (Yingli Green Energympany Limited, 333-142852) that themmission declared effective, with terms of deposit identical to the terms of deposit of this registration statement.]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program NEW YORK and Xianyang, China, The Company’s flagship product is the Xin Ao Xing Oleanolic Acid Capsule, the only SFDA approved OTC drug from the local level to the state level which treats chronic hepatitis B, a condition which affects 10% of the Chinese population. In addition, the]
YGE [YINGLI GREEN ENERGY] POSASR: (Original Filing)
[PROSPECTUS Yingli Green Energympany Limited ORDINARY SHARES PREFERRED SHARES DEPOSITARY SHARES DEBT SECURITIES Each time we or the selling securityholders sell securities we will provide a supplement to this prospectus thatntainsecific informationout the offering and the terms of the securities. The supplement maysod, update or change informationntained in this prospectus. You shouldrefully read this prospectus] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Wensent to the use of our reports with respect to thensolidated financial statements and the effectiveness of internalntrol over financial reportingorporated by reference herein and to the reference to our firm under the heading Experts in the prospectus.]
BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to
[Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program NEW YORK and Xianyang, China, The Company’s flagship product is the Xin Ao Xing Oleanolic Acid Capsule, the only SFDA approved OTC drug from the local level to the state level which treats chronic hepatitis B, a condition which affects 10% of the Chinese population. In addition, the]
